Absci Corp
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treat… Read more
Absci Corp (ABSI) - Total Assets
Latest total assets as of September 2025: $244.99 Million USD
Based on the latest financial reports, Absci Corp (ABSI) holds total assets worth $244.99 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Absci Corp - Total Assets Trend (2019–2024)
This chart illustrates how Absci Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Absci Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Absci Corp's total assets of $244.99 Million consist of 62.7% current assets and 37.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $44.88 Million | 21.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Absci Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Absci Corp's current assets represent 62.7% of total assets in 2024, a decrease from 70.1% in 2019.
- Cash Position: Cash and equivalents constituted 19.3% of total assets in 2024, down from 67.2% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 1.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 21.0% of total assets.
Absci Corp Competitors by Total Assets
Key competitors of Absci Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Absci Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Absci Corp generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Absci Corp is currently not profitable relative to its asset base.
Absci Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.89 | 5.63 | 7.25 |
| Quick Ratio | 5.89 | 5.63 | 7.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $145.29 Million | $ 123.46 Million | $ 63.14 Million |
Absci Corp - Advanced Valuation Insights
This section examines the relationship between Absci Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.64 |
| Latest Market Cap to Assets Ratio | 1.62 |
| Asset Growth Rate (YoY) | -1.7% |
| Total Assets | $213.61 Million |
| Market Capitalization | $345.85 Million USD |
Valuation Analysis
Above Book Valuation: The market values Absci Corp's assets above their book value (1.62 x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Absci Corp's assets decreased by 1.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Absci Corp (2019–2024)
The table below shows the annual total assets of Absci Corp from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $213.61 Million | -1.70% |
| 2023-12-31 | $217.30 Million | -32.31% |
| 2022-12-31 | $321.01 Million | -24.68% |
| 2021-12-31 | $426.19 Million | +381.20% |
| 2020-12-31 | $88.57 Million | +354.88% |
| 2019-12-31 | $19.47 Million | -- |